Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Chemours Company (0HWG) Share Price & Analysis

0HWG Stock Chart & Stats

$13.76$0.60(4.56%)
At close: 4:26 PM GMT
$12.5$15$17.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$12.93 - $13.31
52-Week Range
$10.58 - $29.00
Previous Close
$13.25
Volume
N/A
Average Volume (3M)
1,312
Market Cap
$2.04B
Enterprise Value
$6.55B
Total Cash (Recent Filing)
$671.00M
Total Debt (Recent Filing)
$4.12B
Price to Earnings (P/E)
―
Beta
1.34
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Nov 16, 2026
Dividend Yield
2.66%

Bulls Say, Bears Say

Bulls Say

Growth In Semiconductor And Data-center Applications

Growth in Performance Solutions, supported by semiconductor and data-center demand, indicates traction in technically demanding applications. Increased product trials and early liquid-cooling sales could expand Chemours’ specialty mix and create durable growth opportunities beyond more cyclical chemical markets.

Pricing Power In Titanium Technologies

Successful TiO2 price increases demonstrate some ability to recover costs and improve revenue quality despite volume softness. If pricing holds, it can support margins and cash generation, while reinforcing Chemours’ position in applications where pigment performance remains important to customers.

Improving Cash Generation And Debt Repayment

Positive operating and free cash flow provide an internal funding source for debt reduction and ongoing investment. The recent improvement is especially constructive because management is using organic cash generation to repay borrowings, which can gradually improve financial resilience and reduce interest burden.

Bears Say

Highly Stressed Balance Sheet

High debt combined with negative equity materially limits financial flexibility and increases vulnerability to weaker operating conditions. This capital structure can constrain investment, make refinancing more important, and leave less capacity to absorb volatility while the company works to restore profitability.

Sharp Deterioration In Revenue And Profitability

The steep revenue decline and current loss-making profile show that Chemours’ earnings base remains materially weaker than in prior years. Very low EBITDA profitability reduces the cushion available for debt service and investment, making a sustained recovery in demand, pricing, and costs essential.

Ongoing PFAS-related Cash Obligations

The multi-year PFAS settlement provides greater liability clarity but still creates recurring cash commitments over an extended period. These obligations can absorb a portion of future free cash flow, potentially slowing deleveraging and limiting capital available for operational improvements or growth initiatives.

Chemours Company News

0HWG FAQ

What was Chemours Company’s price range in the past 12 months?
Chemours Company lowest share price was $10.58 and its highest was $29.00 in the past 12 months.
What is Chemours Company’s market cap?
Chemours Company’s market cap is $2.04B.
When is Chemours Company’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chemours Company’s earnings last quarter?
Chemours Company released its earnings results on Nov 02, 2026. The company reported $1.29 earnings per share for the quarter, beating the consensus estimate of $0.266 by $1.024.
Is Chemours Company overvalued?
According to Wall Street analysts Chemours Company’s price is currently Undervalued.
Does Chemours Company pay dividends?
Chemours Company pays a Quarterly dividend of $0.088 which represents an annual dividend yield of 2.66%. See more information on Chemours Company dividends here
What is Chemours Company’s EPS estimate?
Chemours Company’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chemours Company have?
Chemours Company has 150,499,000 shares outstanding.
What happened to Chemours Company’s price movement after its last earnings report?
Chemours Company reported an EPS of $1.29 in its last earnings report, beating expectations of $0.266. Following the earnings report the stock price went down -16.05%.
Which hedge fund is a major shareholder of Chemours Company?
Hedge funds hold Chemours Company shares: the largest hedge-fund position in Chemours Company is 1,903,549,217 shares, and hedge funds decreased their holdings by 889.5K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology